LCI 1335
Pill imprint LCI 1335 has been identified as Doxycycline monohydrate 50 mg.
Doxycycline is used in the treatment of urinary tract infection; chlamydia infection; acne; rosacea; bacterial infection (and more), and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy.
Doxycycline 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Doxycycline monohydrate Images
- Imprint:
-
LCI
1335 - Strength:
- 50 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
corn starch
silicon dioxide colloidal
magnesium stearate
polyvinyl alcohol
titanium dioxide
polyethylene glycol
magnesium silicate
D&C Yellow No. 10
FD&C Yellow No. 6
aluminum oxide
- Drug Class:
- Miscellaneous antimalarials
Tetracyclines - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1335
Advertisement
More Doxycycline Monohydrate resources
- Doxycycline
- Doxycycline (Wolters Kluwer)
- Doxycycline Capsules (Wolters Kluwer)
- Doxycycline Hyclate (Wolters Kluwer)
- Doxycycline Hyclate Delayed-Release Capsules (Wolters Kluwer)
- Doxycycline Hyclate Delayed-Release Tablets (Wolters Kluwer)
- Doxycycline Kit (Wolters Kluwer)
- Doxycycline Monohydrate (Wolters Kluwer)
- Doxycycline Suspension (Wolters Kluwer)
- Doxycycline Syrup (Wolters Kluwer)
- Doxycycline Tablets (Wolters Kluwer)
- Doxycycline with Cleanser (Wolters Kluwer)
- doxycycline (Cerner Multum)
- Adoxa Pak (Micromedex) - Includes Dosage Information
- Atridox (Micromedex) - Includes Dosage Information
- Vibramycin Hyclate (Micromedex) - Includes Dosage Information
- doxycycline (Micromedex) - Includes Dosage Information
- doxycycline Subgingival (Micromedex) - Includes Dosage Information
- Doxycycline (AHFS DI)
- Doxycycline Calcium (AHFS DI)
- Doxycycline Hyclate (AHFS DI)
- Doxycycline Hyclate eent (AHFS DI)
- Doxycycline Monohydrate (AHFS DI)
- Doxycycline (FDA)
- Doxycycline Hyclate (FDA)
- Doxycycline Hyclate Delayed Release (FDA)
- Doxycycline Hyclate Tablets (FDA)
- Doxycycline Injection (FDA)
- Doxycycline Monohydrate (FDA)
- Doxycycline Tablets (FDA)
- Doxycyline Suspension (FDA)
- Doxycycline (Wolters Kluwer)
Doxycycline Monohydrate is associated with the treatment of:
- Acne
- Actinomycosis
- Amebiasis
- Anthrax
- Anthrax Prophylaxis
- Bacterial Infection
- Bartonellosis
- Bronchitis
- Brucellosis
- Bullous Pemphigoid
- Chlamydia Infection
- Cholera
- Cutaneous Bacillus anthracis
- Ehrlichiosis
- Enterocolitis
- Epididymitis, Sexually Transmitted
- Gastroenteritis
- Granuloma Inguinale
- Inclusion Conjunctivitis
- Lyme Disease
- Lyme Disease, Arthritis
- Lyme Disease, Carditis
- Lyme Disease, Erythema Chronicum Migrans
- Lyme Disease, Neurologic
- Lymphogranuloma Venereum
- Malaria
- Malaria Prevention
- Melioidosis
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Ornithosis
- Pelvic Inflammatory Disease
- Pemphigoid
- Pemphigus
- Periodontitis
- Plague
- Pleural Effusion
- Pneumonia
- Proctitis
- Prostatitis
- Psittacosis
- Rabbit Fever
- Rheumatoid Arthritis
- Rickettsial Infection
- Rosacea
- Skin Infection
- STD Prophylaxis
- Syphilis, Early
- Syphilis, Latent
- Tertiary Syphilis
- Trachoma
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Search Again
